WHO ICTRP trial
Chloroquine as an anti-autophagic chemosensitizing drug in stage IV small cell…
NL-OMON37990 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON37990 |
|---|---|
| Public title | Chloroquine as an anti-autophagic chemosensitizing drug in stage IV small cell lung cancer (SCLC) patients: A phase I trial. |
| Scientific title | Chloroquine as an anti-autophagic chemosensitizing drug in stage IV small cell lung cancer (SCLC) patients: A phase I trial. - Chloroquine in small cell lung cancer |
| Primary sponsor | MAASTRO clinic |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Netherlands |
| Conditions | small cell lung cancer;10029107;small cell lung cancer |
| Interventions | Addition of Chloroquine to (chemo)radiotherapy ;autophagy;chloroquine;phase I trial;small cell lung cancer |
| Registration date | May 21, 2012 |
| Target size | 24 |
| Secondary IDs | 2009-014772-22;NCT00969306;NL29321.068.09 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: